Login or sign up
For business

Bioleap, inc.

3.9· 10 reviews
Average ratingAverage
3.9/ 5

Based on 10 reviews

530%
430%
340%
20%
10%
Ask AI

Ask Trustburn about Bioleap, inc.

Based on 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

David Fairchild
Reviews 1

I recently used a company's services and had a positive experience. The team was friendly and knowledgeable, and they provided top-notch service. The website was easy to navigate, and I was able to find all the information I needed. I highly recommend their services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Bioleap, inc.

BioLeap is an emerging drug discovery company enabled by the next generation of computational fragment-based design technology. BioLeap's design platform quickly predicts binding affinity based on thermodynamic principles giving drug designers new insights to efficiently create non-obvious molecules and improve existing molecules. Lack of chemical diversity has blocked the progress of many high-priority targets during the lead identification and lead optimization phase for failure to provide either a suitable chemical starting point or a replacement structural class to a doomed lead series. BioLeap's technology provides a viable alternative to high-throughput screening and traditional shape-based “docking” approaches. BioLeap has identified lead compounds in four collaborative ventures and is seeking new partners who are interested in exploiting its compelling compound design and engineering platform.

Address
6089 johns road
Categories
Biotechnology